🔗 Permalink

Inventor profile of:

Dimiter Dimitrov

City:

Frederick, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-03-14

Top Assignees for applications by Dimiter Dimitrov

The entities that hold a legal rights for patent applications filed by inventor Dimitrov Dimiter:

BIOMED VALLEY DISCOVERIES, INC. 9 Kansas City, MO United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 4 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 3 Washington, DC United States
The United States of America, as Represented by the Secretary, Department of Health and Human Service National Institutes of Health 3 Bethesda, MD United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH 3 Bethesda, MD United States
The Children's Hospital of Philadelphia 2 Philadelphia, PA United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 2 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 2 Bethesda, MD United States
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY 1 Bethesda, MD United States
The Govt. of the United States of America H.H.N.I. H., Office of Technology Transfer 1 Rockville, MD United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF 1 Bethesda, MD United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
BioMed Valley Discoveries, Inc. 1 Kansans City, MO United States
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INTSTITUTES OF HEALTH 1 Bethesda, MD United States

Recent patent applications by Dimitrov Dimiter

Dimiter Dimitrov from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-14

US20240084034A1

Chemistry; metallurgy

GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET

#2 | 2021-06-17

US20210179700A1

Chemistry; metallurgy

Monoclonal antibodies that specifically bind to matrilin 3 and their use

#3 | 2019-08-15

US20190248880A1

Chemistry; metallurgy

Monoclonal antibodies that specifically bind to matrilin-3 and their use

#4 | 2018-11-08

US20180318444A1

Human necessities

Glypican 2 as a cancer marker and therapeutic target

#5 | 2017-12-14

US20170355765A1

Chemistry; metallurgy

TEM8 antibodies and their use in treatment and detection of tumors

#6 | 2017-05-04

US20170119883A1

Human necessities

Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

#7 | 2017-05-04

US20170119882A1

Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells

#8 | 2017-05-04

US20170119881A1

Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

#9 | 2017-04-27

US20170112928A1

Human necessities

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

#10 | 2017-04-27

US20170112927A1

Human necessities

Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

#11 | 2017-04-27

US20170112926A1

Human necessities

Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells

#12 | 2017-04-13

US20170101464A1

Chemistry; metallurgy

Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

#13 | 2017-04-06

US20170095575A1

Human necessities

Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways

#14 | 2016-11-24

US20160340418A1

Chemistry; metallurgy

Agents that specifically bind matrilin-3 and their use

#15 | 2016-09-15

US20160264662A1

Chemistry; metallurgy

TEM8 antibodies and their use in treatment and detection of tumors

#16 | 2013-06-20

US20130156781A1

Human necessities

Anti-DR4 agonist antibodies

InventorID:

298708 ⎘